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N E W  S C I E N C E
DNA is the essence of biological diversity. But it’s responsible for more than just the basics 
like eye color, hair texture or height. At a less 
visible level, DNA also varies our bodies’ reactions 
to our environment. It’s also the foundation of 
personalized medicine, a developing medical model 
that takes our genetic differences into account. 
This new approach may reshape the future of 
diagnostics.
But to get there, environmental effects on DNA 
need to be understood. That’s where Douglas 
Ruden, Ph.D., associate professor and director of 
epigenomics at WSU’s Institute of Environmental 
Health Sciences, comes in. 
As part of his extensive research on lead 
exposure’s genetic effects, Ruden is searching for 
genetic signatures of lead sensitivity to refine 
prevention and treatment of lead poisoning, which 
according to the City of Detroit has affected 58 
percent of Detroit Public Schools’ students.  
Genomes are complex blueprints of our biological 
identities that comprise the complete sequence 
of our genes. Genes are stretches of DNA, and 
DNA is composed of billions of chemical bases 
named either A, T, G or C. But each person’s 
four-letter sequence is patterned differently, with 
different arrangements accounting for different 
traits. If the manifestations of these arrangements 
are understood, then physicians can use this 
information to customize prevention and treatment 
for patients. 
“That’s sort of the fantasy,” said Ruden. “We 
could be two years away from that or it could be 20 
years. But that’s the goal.”
To help reach that goal, Ruden examined the 
genomes of both lead-exposed and healthy fruit 
flies – the same species that led Thomas Hunt 
Morgan to formulate the theory of heredity nearly 
a century ago. Ruden measured the flies’ genetic 
traits, “but instead of something quantitative like 
height, we measured the expression of all 20,000 
genes,” he said. 
What Ruden has found thus far are nearly a 
dozen genetic pathways that are co-regulated by 
lead. Each of these genetic pathways is the sum of 
interactions among genes that produce the lead 
sensitivity trait. But when lead co-regulates this 
process, it is partially controlling how and at what 
rate proteins are being developed, activating some 
genes and turning others off.
“Once lead binds to these transcriptional 
regulators [that dictate gene expression], it activates 
several hundred genes,” said Ruden. “And those 
genes that are activated or suppressed tend to be 
in neural developmental processes, like synapse 
formation.” In fact, lead poisoning manifests 
itself primarily in the central nervous system and 
can cause learning problems, memory loss and 
poor coordination – in addition to a host of other 
symptoms throughout the body.   
Now, Ruden is targeting the location of these 
pathways to identify the transcriptional regulators 
with which lead co-regulates the production of 
many of the body’s molecular elements. And 
finding those regulators will expand the scientific 
understanding of genetic and bioenvironmental 
interactions while bringing the world closer to a day 
when medical diagnostics is as particular as  
our DNA.
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About Dr. Douglas Ruden:     
Dr. Ruden received B.S. degrees in biology and chemistry 
from the California Institute of Technology and a Ph.D. 
in biochemistry from Harvard University. He was a 
postdoctoral fellow at the Max Planck Institute. He joined 
Wayne State University in 2004.
For more information, visit:  
http://www.iehs.wayne.edu/bio.php?id=44317
“Once lead binds to these 
transcriptional regulators…
it activates several hundred 
genes.”
— Dr. Douglas Ruden, Ph.D.
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